Medimix Hematology
  • Home
  • Live from the congress
    • 2025
      • EBMT 2025
    • 2024
      • ASH 2024 (San Diego)
      • EHA 2024 (Madrid)
      • ASCO 2024 (Chicago)
  • Contact
  • Other specialties
    • Dermatology
    • Oncology
  • SIGN UP
  • SIGN IN
    • Login
EHA 2023

Advances in the science and care of persons with bleeding disorders

June 10, 2023

Professor Cathérine Lambert, a hematologist at Cliniques Universitaires Saint-Luc in Brussels, provided us with a comprehensive overview during the ‘Advances in the Science and Care of Persons with Bleeding Disorders’ session.

Her presentation covered various topics, including the assessment of joint health in patients receiving prophylaxis for haemophilia through a cross-sectional survey, an update on the phase 3 ATLAS-PPX study that analysed the efficacy and safety of fitusiran for patients with hemophilia A or B who have switched from prior clothing factor concentrate or bypassing agent prophylaxis, and interim results of the ADVANCE+ study of efgartigimod for patients with primary immune thrombocytopenia. 

With the educational support of:

Tags:

highlight

Share Article

Medimix Hematology

Website created by MediMix © 2025 - Privacy Policy

  • Home
  • Live from the congress
    • 2025
      • EBMT 2025
    • 2024
      • ASH 2024 (San Diego)
      • EHA 2024 (Madrid)
      • ASCO 2024 (Chicago)
  • Contact
  • Other specialties
    • Dermatology
    • Oncology
  • SIGN UP
  • SIGN IN
    • Login
    • Logout
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok